Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TYK MedicinesHKSE:02410 -4.08%7 Market Cap is HK$2,619.63 Mil as of Aug. 01, 2026. GuruFocus rates HKSE:02410 with a GF Score™ of 7/100. The stock has 3 warning signs investors should review. Among 1,422 Biotechnology companies, TYK Medicines ranks better than 66.46% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TYK Medicines's share price for the quarter that ended in Dec. 2025 was HK$13.12. TYK Medicines's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 378.66 Mil. Therefore, TYK Medicines's market cap for the quarter that ended in Dec. 2025 was HK$4,967.95 Mil.
TYK Medicines's quarterly market cap
declined
from Dec. 2024 (HK$18,226.59 Mil) to Jun. 2025 (HK$8,047.14 Mil) and
declined
from Jun. 2025 (HK$8,047.14 Mil) to Dec. 2025 (HK$4,967.95 Mil).
TYK Medicines's annual market cap
increased
from Dec. 2023 (HK$0.00 Mil) to Dec. 2024 (HK$18,226.59 Mil) but then
declined
from Dec. 2024 (HK$18,226.59 Mil) to Dec. 2025 (HK$4,967.95 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TYK Medicines's Enterprise Value for Today is HK$2,429.85 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
TYK Medicines Market Cap Related Terms
TYK Medicines Market Cap Historical Data
* Premium members only.
The historical data trend for TYK Medicines's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02410 vs VRTX, REGN, RVMD: Market Cap Comparison
For the Biotechnology subindustry, TYK Medicines's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TYK Medicines Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TYK Medicines's Market Cap distribution charts can be found below:
* The bar in red indicates where TYK Medicines's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
TYK Medicines's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TYK Medicines (HKSE:02410) has a Market Cap of HK$2,619.63 Mil as of Aug. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TYK Medicines and its competitors. According to the industry distribution chart, TYK Medicines ranks #477 out of 1422 companies in the Biotechnology industry, placing it in the top 33.5%.
Is TYK Medicines' Market Cap too high?
TYK Medicines' current Market Cap is HK$2,619.63 Mil. Based on the distribution chart, TYK Medicines ranks #477 out of 1422 companies in the Biotechnology industry, which is above the industry midpoint. Overall, TYK Medicines has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does TYK Medicines' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TYK Medicines ranks #477 out of 1422 companies for Market Cap. This puts TYK Medicines in the upper half of its industry. The industry median Market Cap is 109.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 109.62, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TYK Medicines and its competitors. For the Biotechnology industry, the median Market Cap is 109.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TYK Medicines's current Market Cap is HK$2,619.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TYK Medicines stock overvalued right now?
TYK Medicines (HKSE:02410) has a current Market Cap of HK$2,619.63 Mil. The current Market Cap is HK$2,619.63 Mil. TYK Medicines' overall GF Score™ is 7/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For TYK Medicines (HKSE:02410), the current Market Cap is HK$2,619.63 Mil as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with10 drug candidates, including Core Product TY-9591, five clinical stage products, and four preclinical stage or early clinical development stage.
7GF Score
Get the complete analysis for HKSE:02410
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02410 has been successfully added to your 
